In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
For the past few decades, clinical trials related to alpha-1 antitrypsin deficiency (AATD), have focused on getting more replacement therapy on the market. New areas of AATD research focus…
Shiv Gaglani and Ryan Haynes, Co-Founders of Osmosis The Osmosis platform utilizes both cognitive techniques and thoughtful user experience design in its forward-thinking application for medical students. The goal…
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults…
New advancements in the field of alpha-1 antitrypsin research hold promise for the treatment and possible reversal of liver disease. Recent advances in the safety and viability of…
Patients diagnosed with Acute Lymphoblastic Leukemia, the most common form of childhood cancer, are typically given Vincristine, a very powerful chemotherapy drug with a high toxicity called neuropathy…
Yelena Havryliuk, MD, FACOG, Assistant Professor of Obstetrics and Gynecology, Weill Cornell Medical College, discusses the top three options for fibroid management. The first treatment option is hormonal…
After two unsuccessful attempts to quit smoking, Jodell Kaiser paid a visit to Mayo Clinic and began using Varenicline, a drug that treats nicotine addiction. A study published…
Shiv Gaglani and Ryan Haynes, Co-Founders of Osmosis, talk about the new mobile learning platform, which is currently being used by over 18,000 medical students. Osmosis is designed…
John Weinberg, MD, COO, Veloxis Pharmaceuticals, describes the benefits of the Veloxis’ Envarsus, an orphan drug for the treatment of organ transplant rejection. Envarsus is a reformulation of tacrolimus,…
Pepper Schwartz, PhD, professor of sociology, University of Washington, offers five romantic ideas for physicians on Valentine’s Day. Schwartz advises physicians to promote seduction, planning a romantic date or…
